Abstract
Objective
This study aimed to analyze the effect of coronary stent policies implemented in Shanghai on the risk of percutaneous coronary intervention (PCI) in acute coronary syndrome (ACS) inpatients based on real-world data.
Methods
Two retrospective cohorts of inpatients with a first diagnosis of ACS who had undergone PCI for the first time in the previous year in Shanghai hospitals were examined (one for the postpolicy period and the other for the prepolicy period). χ2 tests were used to compare categorical variables between the two cohorts. Single- and multivariate Cox proportional hazards models were used to compare the risk of major adverse cardiovascular events (MACEs) between the two cohorts.
Results
A total of 31,760 ACS patients were included in this study. The proportion of ACS inpatients who had at least one bid-winning stent and 3 or more coronary stents implanted for first-time PCI in the postpolicy cohort was higher than that in the prepolicy cohort (86.52% vs. 55.67% and 6.27% vs. 4.39%, respectively; all p values < 0.0001). The single- and multivariate Cox proportional hazards models revealed that the unadjusted and adjusted hazard ratios for MACEs at 1 year after PCI for the postpolicy cohort relative to the prepolicy cohort were 0.869 (P<0.0001) and 0.814 (P = 0.0007), respectively.
Conclusions
The implementation of coronary stent policies changed coronary stent utilization but had no significant adverse effects on the risk of PCI among ACS patients in Shanghai in the short term. However, the reasons for changes in the number of coronary stents implanted should be analyzed and addressed in the future.
Publisher
Public Library of Science (PLoS)
Reference27 articles.
1. WHO. The top 10 causes of death. Published December 9, 2020. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed August 28, 2023.
2. 2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting with ST-Segment Elevation.;B Ibánez;Rev Esp Cardiol (Engl Ed).
3. 2020 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation;JP Collet;Eur Heart J
4. Report on Cardiovascular Health and Diseases in China 2021: an updated summary.;The Writing Committee of the Report on Cardiovascular Health and Diseases in China;Chinese Circulation Journal,2022
5. The Economic Burden of Cardiovascular Disease and Hypertension in Low- and Middle-Income Countries: a systematic review.;A Gheorghe;BMC Public Health,2018